李照强, 黄颖楠, & 杜俊英. (2026). miR-15a、miR-16-1 联合 MEG3 在子宫内膜 癌患者再复发评估中的价值. Journal of Kunming Medical University / Kunming Yike Daxue Xuebao, 47(4), 138. https://doi.org/10.12259/j.issn.2095-610X.S20260417
Chicago Style (17th ed.) Citation李照强, 黄颖楠, and 杜俊英. "MiR-15a、miR-16-1 联合 MEG3 在子宫内膜 癌患者再复发评估中的价值." Journal of Kunming Medical University / Kunming Yike Daxue Xuebao 47, no. 4 (2026): 138. https://doi.org/10.12259/j.issn.2095-610X.S20260417.
MLA (9th ed.) Citation李照强, et al. "MiR-15a、miR-16-1 联合 MEG3 在子宫内膜 癌患者再复发评估中的价值." Journal of Kunming Medical University / Kunming Yike Daxue Xuebao, vol. 47, no. 4, 2026, p. 138, https://doi.org/10.12259/j.issn.2095-610X.S20260417.
Warning: These citations may not always be 100% accurate.
